HR 9900 · 118th Congress · Armed Forces and National Security

BioTech Innovation and National Security Continuation Act

Introduced 2024-10-01· Sponsored by Rep. Khanna, Ro [D-CA-17]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the House Committee on Armed Services.(2024-10-01)

Plain Language Summary

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 9900 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 9900 To modify the National Security Commission on Emergency Biotechnology. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 1, 2024 Mr. Khanna introduced the following bill; which was referred to the Committee on Armed Services _______________________________________________________________________ A BILL To modify the National Security Commission on Emergency Biotechnology. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``BioTech Innovation and National Security Continuation Act''. SEC. 2. MODIFICATION OF NATIONAL SECURITY COMMISSION ON EMERGING BIOTECHNOLOGY. Section 1091 of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117-81) is amended-- (1) in subsection (b)(3) by striking ``the authority to make such appointment or appointments shall expire, and the number of members of the Commission shall be reduced by the nu…

Summarized by Claude AI · Non-partisan · For informational purposes only